AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.
Agricola
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.
American Journal of Clinical Nutrition, Vol. 83, No. 4, 880-886, April 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration1,2,3,4

Chung-Jung Chiu, Larry D Hubbard, Jane Armstrong, Gail Rogers, Paul F Jacques, Leo T Chylack, Jr, Susan E Hankinson, Walter C Willett and Allen Taylor

1 From the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA (C-JC, GR, PFJ, and AT); Harvard Medical School and the Center for Ophthalmic Research, Brigham and Women's Hospital, Boston, MA (LTC); The Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA (SHE and WCW); the Departments of Epidemiology (SHE and WCW) and Nutrition (WCW), Harvard School of Public Health, Boston, MA; the Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI (LDH and JA)

2 Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views or policies of the US Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.

3 Supported by the US Department of Agriculture agreements 58-1950-4-401 and 1950-5100-060-01A (C-JC, GR, PFJ, and AT); the National Research Initiative Competitive Grant Program grants 98-01023 and 92-37200-7704 (AT); the Massachusetts Lions Eye Research Fund (LTC); NIH research grants EY-09611, CA-40356, EY-R01-13250 (AT), and NEI EY014183-01A2 (AT); and the Johnson and Johnson Focused Giving Program (AT). We also gratefully acknowledge the assistance to AT from the Singers and D Gierhardt.

4 Address reprint requests to A Taylor, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111. E-mail: allen.taylor{at}tufts.edu.

See corresponding editorial on page 733.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Several dietary factors have been linked to age-related maculopathy (ARM), the early form of age-related macular degeneration, and there is reason to think that dietary carbohydrate may play a role in the development of ARM.

Objective: The purpose of the present study was to examine the relation between dietary carbohydrate quality, as measured by dietary glycemic index (GI) or total carbohydrate intake, and ARM.

Design: From the Nurses' Health Study, 1036 eyes from 526 Boston-area participants without a previous ARM diagnosis were included in the present study. The presence and degree of ARM were classified by the Age-Related Eye Diseases Study system. Long-term dietary information was based on data from an average of 4 food-frequency questionnaires collected over a 10-y period before the assessment of ARM. With eyes as the unit of analysis, we used a generalized estimating approach to logistic regression to estimate the odds ratios for ARM in a manner that accounted for the lack of independence between the 2 eyes from the same subject.

Results: After multivariate adjustment, dietary GI was related to ARM (specifically to retinal pigmentary abnormalities), whereas total carbohydrate intake was not. The odds ratio for ARM being in the highest tertile of dietary GI (≥77.0) versus the lowest (<74.6) was 2.71 (95% CI: 1.24, 5.93; P for trend = 0.01). Neither dietary GI nor total carbohydrate intake was related to drusen.

Conclusion: Our results suggest that dietary GI may be an independent risk factor for ARM.

Key Words: Age-related macular degeneration • retina • maculopathy • nutrition • vision • carbohydrate • glycemic index • glycation • aging • epidemiology • risk factor • food-frequency questionnaire • drusen • pigment abnormalities


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The macula is located in the center of the retina, where light is converted into electrical impulses before transmission to the brain. The macula enables us to see fine detail and is critical to central vision. Age-related macular degeneration (AMD) is one of the leading causes of irreversible vision loss in Americans 40 y of age and older (1). The prevalence of AMD in this segment of the US population is estimated to be 1.47%, with 1.75 million persons having some manifestation of AMD. The prevalence increases dramatically with age and is >10% among persons older than 80 y (2). Within the next 2 decades, as the number of elderly Americans increases, it is anticipated that the number of AMD cases will increase by 50% to 3 million (2). With no effective therapy for AMD (3), the related social and medical burden will continue to increase. Prevention remains the best approach for addressing this public health issue, and dietary modifications may provide one of the most cost-effective strategies. Several dietary factors have been linked to AMD (4-7). However, to our knowledge, the association between AMD and dietary carbohydrate has not been evaluated. This association is particularly interesting because the retina has among the highest supplies of blood and nutrients, including glucose, and the retina is dependent on adequate glucose delivery from the systemic circulation to maintain its physiologic function (8). Because glucose stores in the retina are negligible, it appears that glucose metabolism is efficient in the retina. Appropriately, the role of glucose in age-related diseases, including AMD (9, 10), is now receiving considerable attention because of the potentially adverse effects of sustained high concentrations of glucose or glucose spike and age-related inefficiencies or improper metabolism, including the formation of advanced glycation end products and their sequelae. Thus, studies have shown that advanced glycation end products accumulate in drusen with age and occur at higher concentrations in patients with AMD (11, 12).

To better understand whether the amount or the quality of dietary carbohydrate may influence the risk of early AMD, referred to as age-related maculopathy (ARM), we examined associations between long-term carbohydrate intake and dietary glycemic index (GI), respectively, and the risk of ARM in a substudy of the Nurses' Health Study (NHS) called the Nutrition and Vision Project (NVP).


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
The NVP, a substudy of the NHS in participants residing in the Boston area, is a collaborative project between Tufts and Harvard Universities (13, 14). In 1993, a total of 1707 women aged 53–73 y, with both lenses intact, with no diagnosis of cancer other than nonmelanoma skin cancer, and with complete dietary data were identified from the NHS cohort with the aim of enrolling 600 women into the NVP. The 1707 candidates were initially contacted by letter to obtain their consent to participate in the NVP. We received positive responses from 730 women (43%), and 603 (83%) of these volunteers were scheduled between April 1993 and August 1995 to undergo baseline data collection, including retina evaluation. The most common reasons for failure to examine nurses who expressed interest in participating (n = 127) were scheduling conflicts due to work and travel. There were few notable differences between participants (n = 603) and nonparticipants (n = 1104) (15). All procedures were approved by the Tufts–New England Medical Center Institutional Review Board and the Brigham and Women's Hospital Human Research Committee.

We excluded those with missing retinal data in both eyes (n = 5), invalid calorie intakes (daily energy intakes outside the range 800–3500 kcal; n = 11), missing covariates (n = 36), and confirmed diagnoses of diabetes in 1990 or earlier (n = 25). Diabetic women were excluded to avoid the potential confounding and modification effects on the association of interest. This left 526 women in the present study. None of the participants had been diagnosed with ARM at baseline.

Assessment of ARM
A standardized ophthalmic examination, including ocular and medical history, Bailey Lovie test of visual acuity and manifest refraction, external ocular examination, applanation tonometry, contrast sensitivity function and glare testing, and a slit-lamp examination of the anterior segment with an assessment of risk for angle closure glaucoma was administered to every NVP participant. Pupils were dilated to a minimum of 6 mm. Stereoscopic color fundus photographs of the macula were taken with a Topcon TRC 50X fundus camera (35-degree setting). At the Fundus Photograph Reading Center (University of Wisconsin, Madison, WI) the images were evaluated for the presence and severity of ARM on the basis of the Age-Related Eye Diseases Study (AREDS) classification (16).

Drusen were assessed with respect to size of individual drusen, cumulative area, and appearance (hard or soft), as described previously in AREDS (16). In brief, the largest drusen diameter and total drusen area were considered as defining the size and extent of drusen, respectively. Drusen size was classified into 3 drusen diameter categories relative to the size of the standardized optic disc (17). The disc diameter (DD), is set at 1500 µm by historical convention. This is equivalent to an area of 1.77 x 106 µm2. Thus, small, intermediate, and large drusen have diameters of <63 µm (1/24 DD), ≥63 µm to <125 µm, and ≥125 µm (1/12 DD), respectively. Under the AREDS scheme, small drusen were considered to be "extensive" when their cumulative area (total drusen area within 2 DD of the center of the macula) was at least that of AREDS standard circle C-1 (with a diameter of 1/12 DD). This corresponds to {approx}15 small drusen as observed in stereo photographs and {approx}5–10 small drusen observed by ophthalmoscopic examination. Intermediate drusen were considered to be "extensive" if any soft indistinct drusen were present and when the total area occupied by them was equivalent to the area that would be occupied by 20 drusen, each with a diameter of 100 µm. This would be equivalent to 1.57 x 105 µm2. If no soft indistinct drusen were present, intermediate drusen were considered to be "extensive" when they occupied an area equivalent to ≥1/5 disc area ({approx}65 100-µm diameter drusen or equivalent to 5.11 x 105 µm2). Other features of ARM are specified in detail in the AREDS grading protocol (16).

Eyes were divided into 3 groups according to the size and extent of drusen and presence of ARM. In the "Unaffected group" are eyes with no drusen or only nonextensive small drusen. To qualify for the "Drusen group," the eye had to have one or more Intermediate drusen (including nonextensive intermediate drusen or extensive small drusen) or Large drusen (including large drusen or extensive intermediate drusen) and no pigmentary abnormalities characteristic of ARM. To qualify for the "ARM group," the eye had to have pigmentary abnormalities, with or without drusen. Eyes presenting with both drusen and ARM were classified into the ARM group. Only 7 eyes had lesions other than drusen and pigmentary abnormalities. Of these, 3 had retinal detachments, 2 had geographic atrophy (GA), 1 had subretinal fibrosis, and 1 had retinal detachment, hard exudates, and subretinal fibrosis. To preserve the homogeneity of the outcome, these eyes were excluded from analysis. Of the 7 eliminated eyes, 3 were graded as advanced (1 of the 2 with GA, the 1 with subretinal fibrosis, and the 1 with retinal detachment, hard exudates, and subretinal fibrosis). The remaining 1036 eyes were from 526 women. Sixteen women contributed only one eye.

To describe the characteristics of these women, each woman was classified into one group based on the grading of both of her eyes. We included in the Unaffected group women with both eyes free of drusen and ARM or women with only nonextensive small drusen in one eye or both eyes. We included in the Drusen group, women without ARM but with one or more of the following: 1) nonextensive intermediate or extensive small drusen (collectively called Intermediate drusen) or 2) large drusen or extensive intermediate drusen (collectively called Large drusen). Women with ARM, or drusen and ARM, in at least one eye were classified into ARM group.

Assessment of nutrition intake
In 1980, a 61-item semiquantitative food-frequency questionnaire (FFQ) was incorporated into the NHS biennial questionnaire (14). The FFQ collected information about usual dietary intakes over the previous year and classified them into 9 possible response categories, which ranged from "never or less than once per month" to "6 or more times per day." Additionally, the 1980 questionnaire collected information on vitamin supplement use and the duration of vitamin supplement use before 1980. The FFQ was revised and expanded in 1984, 1986, and 1990. The present version of the FFQ includes 126 food items and details of vitamin and mineral supplement use that collectively account for >90% of the intake of the 70 nutrients measured by the questionnaire. The FFQ has been comprehensively validated in relation to long-term diet records (18, 19), biochemical markers of nutrient status (20, 21), and individual carbohydrate foods (22). In addition to the FFQs routinely collected as part of the NHS, an additional FFQ was administered as part of the NVP at baseline recruitment (1993–1995). The 4 FFQs, including the 1984, 1986, and 1990 FFQs from the NHS and the NVP baseline FFQ, were used to assess the dietary information. Participants were assigned the mean values for dietary variables, which were determined by averaging values from the 4 FFQs. We did not use the 1980 FFQ, because a more detailed assessment of carbohydrate intake was first undertaken in 1984.

We assessed carbohydrate quality using the GI. Jenkins et al (23) introduced the concept of GI to facilitate the identification of foods that result in relatively low glycemic responses. The GI for a food is defined as the glycemic response (ie, the incremental area under the glucose response curve up to 2 h) after consumption of a fixed amount of carbohydrate from a test food, relative to the glycemic response to a reference food. The GI values for foods in the FFQ were either derived from published values with the use of white bread as the reference food or imputed from GI values of comparable foods (24). The dietary GI for each subject was calculated as the weighted average of the GI scores for each food item, with the amount of carbohydrate consumed from each food item as the weight. The dietary GI values determined for this subcohort of the NHS are comparable with the dietary GI values for the whole NHS (25) and with dietary GI values for other cohorts (26). All dietary variables were energy-adjusted by using the residuals method (27).

Defining nonnutritional variables
Information on known or suspected nonnutritional risk factors for AMD was collected from the biennial NHS questionnaires. For our analyses, age, history of hypertension (yes or no), pack-years of cigarettes smoked (ie, the number of packs of cigarettes smoked per day x the numbers of years of smoking), average alcohol intake, reported summertime sunlight exposure (≥8 h/wk) as reported on the 1980 questionnaire, and body mass index (BMI; calculated in kg/m2 from height and weight as reported on the 1984 questionnaire) were considered as covariates.

Statistical methods
Of 526 women available for the present study, we identified 252 women affected with drusen or ARM in at least one eye. As previously described (see Assessment of ARM), we divided the women into 3 groups: Unaffected group (n = 274), Drusen group (n = 189), and ARM group (n = 63). We first compared the means ± SEs, medians, or proportions of covariates between the unaffected group (n = 274) and the drusen group (n = 189) or ARM group (n = 63). Wilcoxon's two-sample test was used in place of the two-sample t test when the normality assumption was questionable. P values were adjusted by Bonferroni correction.

To evaluate the association between dietary carbohydrate and ARM, we used 1036 available eyes to model the odds of the ARM-related lesions by logistic regression with the SAS GENMOD procedure (28). The generalized estimating equation approach was used to estimate the regression coefficients (29). This procedure adjusts the SEs of regression coefficient estimates for correlated data derived from the use of both eyes of the same individual. Women were divided into 3 categories according to the tertiles of their dietary GI or total carbohydrate intake. Women in the second and third tertile categories were compared with women in the first tertile category. We used 3 models to evaluate the association between dietary GI and total carbohydrate intake and the odds of drusen and ARM. Model 1 included the energy-adjusted carbohydrate variables, either dietary GI or total carbohydrate intake, and age. Model 2 further adjusted for potential confounders, including BMI, alcohol intake, pack-years of cigarettes smoked, hypertension, outdoor sunlight exposure in the summer, and total fat, vitamin C, vitamin E, ß-carotene, zinc, and calorie intakes. These covariates had been related to risk for ARM in prior studies (5-7, 30, 31). Model 3 was created to evaluate the independent effect of quantity and quality of dietary carbohydrate. In this model, total carbohydrate intake and dietary GI were simultaneously included along with the other covariates from model 2.

To test for trends across nutrient tertile categories, we assigned the median value in each category to everyone within the category and then included this median variable as a continuous factor in the logistic regression models. We used a P value <0.05 for significance in the present analyses, and all tests were two-sided. All analyses were performed in SAS (version 8.02; SAS Institute Inc, Cary, NC).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Of the 526 women available for analysis, 274, 189, and 63 women qualified for the Unaffected, Drusen, and ARM groups, respectively (Table 1Go). Women in the Drusen group did not differ significantly from women in the Unaffected group with respect to age, BMI, summer sunlight exposure, alcohol drinking, pack-years of cigarettes smoked, hypertension, dietary GI, total carbohydrate intake, and calorie intake. In comparison, women in the ARM group were significantly older (P = 0.04) and had a marginally higher dietary GI (P = 0.08), but they did not differ from women in the Unaffected group with respect to the other variables noted above.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Characteristics of women by the absence or presence of drusen or age-related maculopathy (ARM) in the 3 subject groups1

 
One thousand and thirty-six eyes, including 273 eyes with drusen, 71 eyes with pigmentary abnormalities characteristic of ARM, and 692 eyes without lesions were available (Table 2Go). Neither dietary GI nor total carbohydrate intake was associated with drusen. There was also no association between dietary carbohydrate variables and either extensive intermediate or large drusen (Large drusen; n = 60) or small extensive or nonextensive intermediate drusen (Intermediate drusen; n = 213) (data not shown). In contrast, dietary GI was significantly and positively associated with ARM. The age-adjusted (model 1) and multivariate-adjusted (model 2) ORs for the third tertile category of dietary GI were >2-fold higher. The mutual adjustment of total carbohydrate intake and dietary GI in the model (model 3) did not substantially affect the ORs for either association with ARM. The OR for the third tertile category of dietary GI was 2.71 (95% CI: 1.24, 5.93; P for trend = 0.01). Total carbohydrate intake was not associated with the risk of ARM.


View this table:
[in this window]
[in a new window]
 
TABLE 2 Age- and multivariate-adjusted odds ratios (ORs) and 95% CIs relating the dietary glycemic index (GI) and total carbohydrate intake to age-related maculopathy (ARM): analysis by eye1

 
Of the 7 eliminated eyes with ARM, other than pigmentary abnormalities, 4 were graded as early (see Assessment of ARM). We also separately examined the results for all early ARM (n = 75), including 71 pigmentary abnormalities and the 4 early stage lesions, but the findings did not change. We also analyzed the data using extensive intermediate or large drusen (Large drusen) along with pigmentary abnormalities as early ARM cases, because some studies include both categories as cases of early ARM (32, 33). Similar, but attenuated, findings were seen and this association was primarily due to the positive association between pigmentary abnormalities and dietary GI, because we did not find any associations between extensive intermediate or large drusen (Large drusen) and carbohydrate variables (data not shown).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Our results showed that retinal pigment abnormalities characteristic of ARM are positively associated with long-term dietary GI in the NVP cohort, and this association is independent of total carbohydrate intake and currently known or suspected risk factors. According to our data, when total carbohydrate intake was held constant, there was a more than 2-fold higher odds for ARM in participants with dietary GI in the highest versus lowest third of the study sample.

In the present study, no association was found between drusen and the dietary carbohydrate variables considered here. This may appear surprising because ARM is often accompanied by drusen at diagnosis, and all forms of drusen examined appear to have similar carbohydrate components (34, 35). In addition, several studies reported that advanced glycation end products accumulate in drusen with age and occur at a higher concentration in patients with AMD (11, 12). We also analyzed the data by assigning small nonextensive drusen to the Drusen group rather than to the Unaffected group and by using 1984 carbohydrate variables to reflect intake earlier in life than is represented by the average from the 4 FFQs, but the findings did not change (data not shown). There was no association between Large drusen and Intermediate drusen, respectively, and carbohydrate variables (data not shown). Our failure to find an association, if it does exist, may imply that carbohydrate exposure before the time in life when the dietary data were collected could have been responsible for drusen formation. This is suggested in reports that drusen occur as early as age 50 y (30). In addition, we classified drusen by human grading of color fundus photographs (16). This scheme was developed to provide clinical reliability (36), but it may be insensitive to detecting the very earliest stages of drusen (37). Thus, the "unaffected" eyes may contain early stage drusen, which results in diminished power to detect the association. In our previous study, derived from the same cohort (38), long-term carbohydrate intake was associated with the odds of cortical lens opacities. Moreover, cataracts have been identified as a potential risk factor for ARM in some studies (31, 39). In the present analyses, we also examined the results with further adjustment for the presence of lens opacity in the multivariate analyses (data not shown). The status of lens opacity did not substantially change or confound our findings.

Although the detailed mechanism that explains the association between dietary GI and ARM remains to be elucidated, prior studies indicate that several hyperglycemia-mediated pathways could at least partially explain this pathologic process (8). These pathways include glycation and glycoxidation (or oxidation of glycated moieties), oxidative stress, activation of protein kinase C, direct toxic effects of glucose on the retinal pigment epithelium and capillary endothelium of blood retinal barrier, and associated inflammatory and angiogenic responses (11, 40-44). Notably, a high-GI diet has been proposed to play a role in exacerbating the proinflammatory process (45), and it is plausible that hyperglycemia-mediated damage occurs below the diabetic threshold (46).

To anticipate limitations of this study, we considered several sources of bias that could account for the observed association between dietary GI and ARM. Several aspects of this study argue against such bias. First, it is unlikely that women with high-GI diets are more likely to be identified as having ARM because our retinal classifications were performed in an independent center by graders to whom our nutrition data were masked. In addition, at study onset, none of the participants had been diagnosed with ARM. Second, although the onset of visual symptoms resulting from ARM might affect dietary reporting, visual acuity was similar in the Unaffected, Drusen, and ARM groups (data not shown) because of the early nature of these lesions. Third, at the time of this study, there were no prior studies that related dietary carbohydrate to ARM. Thus, it is unlikely that the participants would have modified their diets based on such relations. For these reasons, family history of ARM is unlikely to have confounded our results. Fourth, dietary data were collected over a period of {approx}10 y, a period of time that may have predated the macular lesions. Fifth, because the dietary data were collected well in advance of eye examinations, it is unlikely that there could have been any change in dietary behavior elicited by recruitment into this study. Nevertheless, although we adjusted for known and suspected risk factors in our analyses, confounding by unknown risk factors remains a possibility and it is possible that inadequate control of confounders may account for the observed association. It is useful to note that the definition of dietary GI is based on an arithmetic sum of GIs of individual foods. It does not account for the possible effects of other nutrients on the digestion, absorption, and metabolism of carbohydrate. Thus, it may be an imperfect index for the glycemic effect of a mixed meal. Finally, chance may have accounted for some type I errors, particularly given that we evaluated several nutrients in our analyses. Further studies are needed to confirm the observed association.

In conclusion, our results suggest a new ARM risk factor: dietary GI. Although our data cannot establish that the observed association is causal, they indicate a new direction for further studies. The results of such studies may ultimately prove helpful in preventing or delaying the onset of ARM and its related disability and costs.


    ACKNOWLEDGMENTS
 
All coauthors contributed substantially to this manuscript. C-JC, LDH, PFJ, LTC, WCW, SEH, and AT were responsible for the design and concept of the project. C-JC, GR, PFJ, and AT participated in the data analysis and writing of the manuscript. AT conceived of the project, arranged for the various institutes to collaborate, and obtained funding. WCW, SEH, and LTC helped prepare the manuscript and arranged for the funding. LDH and JA directed the collection of the ophthalmologic data. WCW and SEH arranged for the collection of the nutritional and personal health data. None of the authors had a conflict of interest.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–85.[Abstract/Free Full Text]
  2. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-72.[Abstract/Free Full Text]
  3. Klein R, Klein BE, Marino EK, et al. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003; 110: 25-33.[Medline]
  4. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701-8.[Abstract]
  5. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001; 73: 209-18.[Abstract/Free Full Text]
  6. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-36.[Abstract/Free Full Text]
  7. Mares-Perlman J, Klein R. Diet and age-related macular degeneration. In: Taylor A, ed. Nutritional and environmental influences on the eye. Boca Raton, FL: CRC Press, 1999: 181-214.
  8. Kumagai AK. Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab Res Rev 1999; 15: 261-73.[Medline]
  9. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85: 746-53.[Free Full Text]
  10. Suji G, Sivakami S. Glucose, glycation and aging. Biogerontology 2004; 5: 365-73.[Medline]
  11. Hammes HP, Hoerauf H, Alt A, et al. N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999; 40: 1855-9.[Abstract/Free Full Text]
  12. Farboud B, Aotaki-Keen A, Miyata T, Hjelmeland LM, Handa JT. Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye. Mol Vis 1999; 5: 11.[Medline]
  13. Taylor A, Jacques PF, Chylack LT Jr, et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 2002; 75: 540-9.[Abstract/Free Full Text]
  14. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med 1987; 316: 22-8.[Abstract]
  15. Jacques PF, Chylack LTJ, Hankinson SE, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119: 1009-19.[Abstract/Free Full Text]
  16. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132: 668-81.[Medline]
  17. Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD. Subretinal fibrosis in diabetic macular edema. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1997; 115: 873-7. (ETDRS report 23.)[Abstract]
  18. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.[Abstract/Free Full Text]
  19. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992; 135: 1114-26.[Abstract/Free Full Text]
  20. Willett WC, Stampfer MJ, Underwood BA, Speizer FE, Rosner B, Hennekens CH. Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels. Am J Clin Nutr 1983; 38: 631-9.[Abstract/Free Full Text]
  21. Ascherio A, Stampfer MJ, Colditz GA, Rimm EB, Litin L, Willett WC. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J Nutr 1992; 122: 1792-801.[Abstract/Free Full Text]
  22. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858-67.[Abstract/Free Full Text]
  23. Jenkins DJ, Wolever TM, Taylor RH. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362-6.[Abstract/Free Full Text]
  24. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76: 5-56.[Abstract/Free Full Text]
  25. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000; 71: 1455-61.[Abstract/Free Full Text]
  26. Jonas CR, McCullough ML, Teras LR, Walker-Thurmond KA, Thun MJ, Calle EE. Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003; 12: 573-7.[Abstract/Free Full Text]
  27. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17-27.[Free Full Text]
  28. The SAS System for Windows. Release 8.2 ed. Cary, NC: SAS Institute Inc, 1999-2001.
  29. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-30.[Medline]
  30. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001; 20: 227-53.[Medline]
  31. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 2000; 107: 2224-32.[Medline]
  32. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999; 117: 1203-10.[Abstract/Free Full Text]
  33. Wong TY, Klein R, Nieto FJ, et al. Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002; 134: 828-35.[Medline]
  34. Mullins RF, Johnson LV, Anderson DH, Hageman GS. Characterization of drusen-associated glycoconjugates. Ophthalmology 1997; 104: 288-94.[Medline]
  35. Mullins RF, Hageman GS. Human ocular drusen possess novel core domains with a distinct carbohydrate composition. J Histochem Cytochem 1999; 47: 1533-9.[Abstract/Free Full Text]
  36. Klein R, Davis MD, Magli YL, Segal P, Klein BEK, Hubard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-34.[Medline]
  37. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-95.[Medline]
  38. Chiu CJ, Morris MS, Rogers G, et al. Carbohydrate intake and glycemic index in relation to the odds of early cortical and nuclear lens opacities. Am J Clin Nutr 2005; 81: 1411-6.[Abstract/Free Full Text]
  39. Klein R, Klein BEK, Wang Q, Moss SE. Is age-related maculopathy associated with cataracts? Arch Ophthalmol 1994; 112: 191-6.[Abstract]
  40. Honda S, Farboud B, Hjelmeland LM, Handa JT. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest Ophthalmol Vis Sci 2001; 42: 2419-25.[Abstract/Free Full Text]
  41. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134: 411-31.[Medline]
  42. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705-32.[Medline]
  43. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20: 385-414.[Medline]
  44. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-10.[Abstract/Free Full Text]
  45. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002; 75: 492-8.[Abstract/Free Full Text]
  46. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.[Abstract/Free Full Text]
Received for publication June 30, 2005. Accepted for publication October 18, 2005.


Related articles in AJCN:

Diet and age-related macular degeneration: expanding our view
Julie A Mares and Suzen M Moeller
AJCN 2006 83: 733-734. [Full Text]  



This article has been cited by other articles:


Home page
IOVSHome page
S.-J. Chen, C.-Y. Cheng, K.-L. Peng, A.-F. Li, W.-M. Hsu, J.-H. Liu, and P. Chou
Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in an Elderly Chinese Population in Taiwan: The Shihpai Eye Study
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3126 - 3133.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. W-T. Chong, A. J. Kreis, T. Y. Wong, J. A. Simpson, and R. H. Guymer
Dietary {omega}-3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration: A Systematic Review and Meta-analysis
Arch Ophthalmol, June 1, 2008; 126(6): 826 - 833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. W Barclay, P. Petocz, J. McMillan-Price, V. M Flood, T. Prvan, P. Mitchell, and J. C Brand-Miller
Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. Du, D. L van der A, M. M. van Bakel, C. J. van der Kallen, E. E Blaak, M. M. van Greevenbroek, E. H. Jansen, G. Nijpels, C. D. Stehouwer, J. M Dekker, et al.
Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 655 - 661.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. D O'Connell, J. M Nolan, J. Stack, D. Greenberg, J. Kyle, L. Maddock, and S. Beatty
Diet and risk factors for age-related maculopathy
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 712 - 722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C.-J. Chiu, R. C Milton, R. Klein, G. Gensler, and A. Taylor
Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1210 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C.-J. Chiu, R. C Milton, G. Gensler, and A. Taylor
Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 180 - 188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. A Mares and S. M Moeller
Diet and age-related macular degeneration: expanding our view.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 733 - 734.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.
Agricola
Right arrow Articles by Chiu, C.-J.
Right arrow Articles by Taylor, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS